Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Journal for ImmunoTherapy of Cancer, 8, 1, S. e000333-
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2020
- Event
-
Veröffentlichung
- (where)
-
London
- (who)
-
BMJ
- (when)
-
2020
- Creator
-
Amaral, Teresa
Kiecker, Felix
Schäfer, Sarah
Stege, Henner
Kähler, Katharina C.
Terheyden, Patrick
Gesierich, Anja
Gutzmer, Ralf
Haferkamp, Sebastian
Uttikal, Jochen
Berking, Carola
Rafei-Shamsabadi, David
Reinhardt, Lydia
Meier, Friedegund
Karoglan, Ante
Posch, Christian
Gambichler, Thilo
Pfoehler, Claudia
Thoms, Kai
Tietze, Julia
Debus, Dirk
Herbst, Rudolf
Emmert, Steffen
Loquai, Carmen
Hassel, Jessica C.
Meiß, Frank
Tueting, Thomas
Heinrich, Vanessa
Eigentler, Thomas
Garbe, Claus
Zimmer, Lisa
- DOI
-
10.1136/jitc-2019-000333
- URN
-
urn:nbn:de:bvb:384-opus4-771092
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Amaral, Teresa
- Kiecker, Felix
- Schäfer, Sarah
- Stege, Henner
- Kähler, Katharina C.
- Terheyden, Patrick
- Gesierich, Anja
- Gutzmer, Ralf
- Haferkamp, Sebastian
- Uttikal, Jochen
- Berking, Carola
- Rafei-Shamsabadi, David
- Reinhardt, Lydia
- Meier, Friedegund
- Karoglan, Ante
- Posch, Christian
- Gambichler, Thilo
- Pfoehler, Claudia
- Thoms, Kai
- Tietze, Julia
- Debus, Dirk
- Herbst, Rudolf
- Emmert, Steffen
- Loquai, Carmen
- Hassel, Jessica C.
- Meiß, Frank
- Tueting, Thomas
- Heinrich, Vanessa
- Eigentler, Thomas
- Garbe, Claus
- Zimmer, Lisa
- Universität Augsburg
- BMJ
Time of origin
- 2020
Other Objects (12)
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients
Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease
Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma
Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity
Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab
Primary Pleural Angiosarcoma Treated with Nivolumab and Ipilimumab: A Case Report
Long-Term Remission with Ipilimumab/Nivolumab in Two Patients with Different Soft Tissue Sarcoma Subtypes and No PD-L1 Expression
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma
Ipilimumab in patients with melanoma and autoimmune disease
18F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab
Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine
Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients
Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease
Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma
Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity
Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab
Primary Pleural Angiosarcoma Treated with Nivolumab and Ipilimumab: A Case Report
Long-Term Remission with Ipilimumab/Nivolumab in Two Patients with Different Soft Tissue Sarcoma Subtypes and No PD-L1 Expression
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma
Ipilimumab in patients with melanoma and autoimmune disease
18F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab
Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine
Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients
Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease
Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma
Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity
Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab
Primary Pleural Angiosarcoma Treated with Nivolumab and Ipilimumab: A Case Report
Long-Term Remission with Ipilimumab/Nivolumab in Two Patients with Different Soft Tissue Sarcoma Subtypes and No PD-L1 Expression
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma
Ipilimumab in patients with melanoma and autoimmune disease
18F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab
Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine